n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with swainsonine in 1 studies
Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (swainsonine) | Trials (swainsonine) | Recent Studies (post-2010) (swainsonine) |
---|---|---|---|---|---|
79 | 1 | 16 | 614 | 7 | 138 |
Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | swainsonine (IC50) |
---|---|---|---|
Chain A, Alpha-mannosidase Ii | Drosophila melanogaster (fruit fly) | 0.02 | |
Chain A, ALPHA-MANNOSIDASE II | Drosophila melanogaster (fruit fly) | 0.02 | |
Chain A, Alpha-mannosidase Ii | Drosophila melanogaster (fruit fly) | 0.02 | |
Lysosomal alpha-mannosidase | Homo sapiens (human) | 0.03 | |
Alpha-mannosidase 2C1 | Rattus norvegicus (Norway rat) | 1.75 | |
Mannosyl-oligosaccharide alpha-1,2-mannosidase IA | Drosophila melanogaster (fruit fly) | 0.005 | |
alpha-1,2-Mannosidase | Glycine max (soybean) | 0.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and swainsonine
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |